ArticleClinical cancer research : an official journal of the American Association for Cancer Research2012

Phase I and pharmacologic trial of cytosine arabinoside with the selective checkpoint 1 inhibitor Sch 900776 in refractory acute leukemias.

Judith E Karp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.